Pulmonary HTN

Pulmonary hypertension (PH) is a common complication of mitral valve disease, and it can impact mitral valve surgery in several ways[1][3][4]. Here are some ways in which PH can impact mitral valve surgery:

• PH can increase the risk of complications during and after surgery, such as bleeding, infection, and heart failure[1][3].
• PH can make it more difficult to repair or replace the mitral valve, as the high pressure in the pulmonary arteries can make it harder for blood to flow through the lungs[1][3].
• PH can affect the outcomes of mitral valve surgery, as patients with PH may have a higher risk of mortality and readmissions for heart failure after surgery[2].
• PH can persist even after successful mitral valve surgery, which may require additional treatment[3].

Despite these challenges, mitral valve surgery can still be safe and effective for patients with PH[2][5]. In some cases, transcatheter mitral valve repair may be an option for patients with severe PH who are not candidates for surgery[2]. The decision to perform mitral valve surgery in patients with PH should be made on a case-by-case basis, taking into account the severity of the PH, the patient's overall health, and the risks and benefits of surgery[1][6].

Citations:
[1] https://pubmed.ncbi.nlm.nih.gov/18365562/
[2] https://jamanetwork.com/journals/jamacardiology/fullarticle/2755896
[3] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5974123/
[4] https://www.ahajournals.org/doi/10.1161/JAHA.113.000748
[5] https://www.ahajournals.org/doi/full/10.1161/01.cir.92.9.137
[6] https://www.jtcvs.org/article/S0022-5223(16)31450-7/fulltext